AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteWR 1065, a dephosphorylated metabolite of amifostine (Ethyol), can protect against the immediate and delayed effects of radiation exposure.
More Information Supplier PageWR 1065, a dephosphorylated metabolite of amifostine (Ethyol), can protect against the immediate and delayed effects of radiation exposure.
More Information Supplier PageWS3 is a ?? cell proliferation inducer via modulation of Erb3 binding protein-1 (EBP1) and the I??B kinase pathway.
More Information Supplier PageWS3 is a ?? cell proliferation inducer via modulation of Erb3 binding protein-1 (EBP1) and the I??B kinase pathway.
More Information Supplier PageWS3 is a ?? cell proliferation inducer via modulation of Erb3 binding protein-1 (EBP1) and the I??B kinase pathway.
More Information Supplier PageWS3 is a ?? cell proliferation inducer via modulation of Erb3 binding protein-1 (EBP1) and the I??B kinase pathway.
More Information Supplier PageWS6 is a ?? cell proliferation inducer via modulation of Erb3 binding protein-1 (EBP1) and the I??B kinase pathway.
More Information Supplier PageWS6 is a ?? cell proliferation inducer via modulation of Erb3 binding protein-1 (EBP1) and the I??B kinase pathway.
More Information Supplier PageWS6 is a ?? cell proliferation inducer via modulation of Erb3 binding protein-1 (EBP1) and the I??B kinase pathway.
More Information Supplier PageWS6 is a ?? cell proliferation inducer via modulation of Erb3 binding protein-1 (EBP1) and the I??B kinase pathway.
More Information Supplier PageWST-8 is a next generation tetrazolium reagent that serves as a sensitive chromogenic indicator for NADH.
More Information Supplier PageWST-8 is a next generation tetrazolium reagent that serves as a sensitive chromogenic indicator for NADH.
More Information Supplier PageWST-8 is a next generation tetrazolium reagent that serves as a sensitive chromogenic indicator for NADH.
More Information Supplier PageWYE-125132 is an ATP-competitive and specific inhibitor of mTORC1 and mTORC2 (IC50 = 0.19 nM; >5,000-fold selective versus PI3Ks).
More Information Supplier PageWYE-125132 is an ATP-competitive and specific inhibitor of mTORC1 and mTORC2 (IC50 = 0.19 nM; >5,000-fold selective versus PI3Ks).
More Information Supplier PageWYE-125132 is an ATP-competitive and specific inhibitor of mTORC1 and mTORC2 (IC50 = 0.19 nM; >5,000-fold selective versus PI3Ks).
More Information Supplier PageWYE-125132 is an ATP-competitive and specific inhibitor of mTORC1 and mTORC2 (IC50 = 0.19 nM; >5,000-fold selective versus PI3Ks).
More Information Supplier PageWYE-125132 is an ATP-competitive and specific inhibitor of mTORC1 and mTORC2 (IC50 = 0.19 nM; >5,000-fold selective versus PI3Ks).
More Information Supplier PageWYE-354 is a potent cell-permeable inhibitor of mTOR (IC50 = 4.3 nM) which blocks signaling through both mTOR complex 1 (mTORC1) and mTORC2. It is a much weaker inhibitor of PI3K ?? (IC50 = 1026 nM) and other kinases.
More Information Supplier PageWYE-354 is a potent cell-permeable inhibitor of mTOR (IC50 = 4.3 nM) which blocks signaling through both mTOR complex 1 (mTORC1) and mTORC2. It is a much weaker inhibitor of PI3K ?? (IC50 = 1026 nM) and other kinases.
More Information Supplier PageWYE-354 is a potent cell-permeable inhibitor of mTOR (IC50 = 4.3 nM) which blocks signaling through both mTOR complex 1 (mTORC1) and mTORC2. It is a much weaker inhibitor of PI3K ?? (IC50 = 1026 nM) and other kinases.
More Information Supplier PageWYE-354 is a potent cell-permeable inhibitor of mTOR (IC50 = 4.3 nM) which blocks signaling through both mTOR complex 1 (mTORC1) and mTORC2. It is a much weaker inhibitor of PI3K ?? (IC50 = 1026 nM) and other kinases.
More Information Supplier PageWYE-354 is a potent cell-permeable inhibitor of mTOR (IC50 = 4.3 nM) which blocks signaling through both mTOR complex 1 (mTORC1) and mTORC2. It is a much weaker inhibitor of PI3K ?? (IC50 = 1026 nM) and other kinases.
More Information Supplier PageWYE-687 is a novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin(mTOR).
More Information Supplier PageWYE-687 is a novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin(mTOR).
More Information Supplier PageWYE-687 is a novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin(mTOR).
More Information Supplier PageWYE-687 is a novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin(mTOR).
More Information Supplier PageWZ3146 is an inhibitor of EGFR receptor kinase mutants carrying a mutation in an active site gatekeeper residue (T790M) and is much less potent against wild-type EGFR kinase.
More Information Supplier PageWZ3146 is an inhibitor of EGFR receptor kinase mutants carrying a mutation in an active site gatekeeper residue (T790M) and is much less potent against wild-type EGFR kinase.
More Information Supplier PageWZ3146 is an inhibitor of EGFR receptor kinase mutants carrying a mutation in an active site gatekeeper residue (T790M) and is much less potent against wild-type EGFR kinase.
More Information Supplier PageWZ3146 is an inhibitor of EGFR receptor kinase mutants carrying a mutation in an active site gatekeeper residue (T790M) and is much less potent against wild-type EGFR kinase.
More Information Supplier PageWZ3146 is an inhibitor of EGFR receptor kinase mutants carrying a mutation in an active site gatekeeper residue (T790M) and is much less potent against wild-type EGFR kinase.
More Information Supplier PageWZ4002 is EGFR inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib.
More Information Supplier PageWZ4002 is EGFR inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib.
More Information Supplier PageWZ4002 is EGFR inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib.
More Information Supplier PageWZ4002 is EGFR inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib.
More Information Supplier PageWZ4002 is EGFR inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 50% of clinically resistant patients to gefitinib or erlotinib.
More Information Supplier PageWZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2
More Information Supplier PageWZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2
More Information Supplier PageWZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2
More Information Supplier PageWZ8040 is a novel EGFR inhibitors that suppress the growth of EGFR-T790M-containing cell lines and inhibit EGFR phosphorylation.
More Information Supplier PageWZ8040 is a novel EGFR inhibitors that suppress the growth of EGFR-T790M-containing cell lines and inhibit EGFR phosphorylation.
More Information Supplier PageWZ8040 is a novel EGFR inhibitors that suppress the growth of EGFR-T790M-containing cell lines and inhibit EGFR phosphorylation.
More Information Supplier PageWZ8040 is a novel EGFR inhibitors that suppress the growth of EGFR-T790M-containing cell lines and inhibit EGFR phosphorylation.
More Information Supplier PageWZ8040 is a novel EGFR inhibitors that suppress the growth of EGFR-T790M-containing cell lines and inhibit EGFR phosphorylation.
More Information Supplier Page
